Los Angeles Hematology Oncology Medical Group — Los Angeles, California

Los Angeles Hematology Oncology Medical Group is a clinical research site located in Los Angeles, California, United States 90017.

Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.

Los Angeles Hematology Oncology Medical Group has participated in 33 clinical trials with 10 currently active.

Therapeutic areas: Breast Neoplasms, Non-Small Cell Lung Cancer, Breast Cancer.

Sponsors: Merck Sharp & Dohme LLC, Hoffmann-La Roche, Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

Sponsor Feasibility Report

Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Los Angeles Hematology Oncology Medical Group?

Los Angeles Hematology Oncology Medical Group has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Los Angeles Hematology Oncology Medical Group conducted?

Los Angeles Hematology Oncology Medical Group has 33 clinical trials on record, with 10 currently active. Their work covers Breast Neoplasms, Non-Small Cell Lung Cancer, Breast Cancer.

Is Los Angeles Hematology Oncology Medical Group accredited by Crixeo Clinical Trials?

Los Angeles Hematology Oncology Medical Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Los Angeles Hematology Oncology Medical Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.